Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells
<p>Abstract</p> <p>Background</p> <p>Inability to control autoimmunity is the primary barrier to developing a cure for type 1 diabetes (T1D). Evidence that human cord blood-derived multipotent stem cells (CB-SCs) can control autoimmune responses by altering regulatory T...
Main Authors: | Zhao Yong, Jiang Zhaoshun, Zhao Tingbao, Ye Mingliang, Hu Chengjin, Yin Zhaohui, Li Heng, Zhang Ye, Diao Yalin, Li Yunxiang, Chen Yingjian, Sun Xiaoming, Fisk Mary, Skidgel Randal, Holterman Mark, Prabhakar Bellur, Mazzone Theodore |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | BMC Medicine |
Online Access: | http://www.biomedcentral.com/1741-7015/10/3 |
Similar Items
-
Differentiation of human multipotent dermal fibroblasts into islet-like cell clusters
by: Liu Wei, et al.
Published: (2010-06-01) -
Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice.
by: Yong Zhao, et al.
Published: (2009-01-01) -
Human Fallopian tube as a novel source of multipotent stem cells with potential for islet neogenesis
by: Kadam SS, et al.
Published: (2009-01-01) -
The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord
by: Arathi Jayaraman, et al.
Published: (2017-12-01) -
Multipotent mesenchymal stromal cells enhance insulin secretion from human islets via N-cadherin interaction and prolong function of transplanted encapsulated islets in mice
by: Elisa Montanari, et al.
Published: (2017-09-01)